Related Experiment Video
Updated: Aug 26, 2026

Measuring Changes in Brain Endothelial Barrier Integrity with Two Impedance-based Biosensors in Response to Cancer Cells and Cytokines
Published on: September 22, 2023
Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression
Anna Bagnato1, Laura Rosanò, Francesca Spinella
1Laboratory of Molecular Pathology and Ultrastructure, Regina Elena Cancer Institute, Via delle Messi d'Oro 156, 00158 Rome, Italy. bagnato@ifo.it
Abstract:
Phenotypic and genotypic analyses of cutaneous melanoma have identified the endothelin B receptor (ET(B)R) as tumor progression marker, thus representing a potential therapeutic target. Here, we demonstrate that activation of ET(B)R by endothelin-1 (ET-1) and ET-3 leads to loss of expression of the cell adhesion molecule E-cadherin and associated catenin proteins and gain of N-cadherin expression. Exposure of melanoma cells to ET-1 leads to a 60% inhibition in intercellular communication by inducing phosphorylation of gap junctional protein connexin 43. Additionally, activation of the ET(B)R pathway increases alpha(v)beta(3) and alpha(2)beta(1) integrin expression and matrix metalloproteinase (MMP)-2 and MMP-9, membrane type-1-MMP activation, and tissue inhibitor MMP-2 secretion. The ET(B)R pathway results into the downstream activation of focal adhesion kinase and extracellular signal-regulated kinase 1/2 signaling pathways, which lead to enhanced cell proliferation, adhesion, migration, and MMP-dependent invasion. The small molecule A-192621, an orally bioavailable nonpeptide ET(B)R antagonist, significantly inhibits melanoma growth in nude mice. These findings demonstrate that ET-1 and ET-3 through ET(B)R activation trigger signaling pathways involved in events associated with disruption of normal host-tumor interactions and progression of cutaneous melanoma. Pharmacological interruption of ET(B)R signaling may represent a novel therapeutic strategy in the treatment of this malignancy.
Insights
Activation of the endothelin B receptor (ET(B)R) by endothelin-1 and ET-3 promotes melanoma progression by altering cell adhesion and increasing invasion. An ET(B)R antagonist inhibited melanoma growth, suggesting a new therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- The endothelin B receptor (ET(B)R) is implicated in cutaneous melanoma progression.
- ET(B)R presents a potential therapeutic target for melanoma treatment.
Purpose of the Study:
- To investigate the role of ET(B)R activation in melanoma cell signaling and progression.
- To evaluate the therapeutic potential of ET(B)R antagonists in melanoma.
Main Methods:
- Melanoma cells were treated with endothelin-1 (ET-1) and ET-3 to activate ET(B)R.
- Changes in cell adhesion molecules (E-cadherin, N-cadherin), intercellular communication (connexin 43), integrin expression, and matrix metalloproteinases (MMPs) were assessed.
- Downstream signaling pathways (FAK, ERK1/2) were analyzed.
- Melanoma growth was evaluated in vivo using an ET(B)R antagonist (A-192621) in nude mice.
Main Results:
- ET(B)R activation led to decreased E-cadherin and increased N-cadherin expression, disrupting cell adhesion.
- Intercellular communication was inhibited by 60% via connexin 43 phosphorylation.
- Increased expression of alpha(v)beta(3) and alpha(2)beta(1) integrins, MMP-2, MMP-9, and membrane type-1-MMP was observed.
- Downstream activation of FAK and ERK1/2 pathways promoted cell proliferation, migration, and invasion.
- The ET(B)R antagonist A-192621 significantly inhibited melanoma tumor growth in vivo.
Conclusions:
- ET(B)R activation by ET-1 and ET-3 drives melanoma progression through modulation of cell adhesion, communication, and invasion pathways.
- Targeting ET(B)R signaling offers a promising novel therapeutic strategy for cutaneous melanoma.
More Related Videos
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Overview of Cell-Matrix Interactions